| Literature DB >> 31905716 |
Masoud Hamidi1,2, Pouya Safarzadeh Kozani2, Pooria Safarzadeh Kozani3, Guillaume Pierre4, Philippe Michaud4, Cédric Delattre4,5.
Abstract
Natural bioactive compounds with antioxidant activity play remarkable roles in the prevention of reactive oxygen species (ROS) formation. ROS, which are formed by different pathways, have various pathological influences such as DNA damage, carcinogenesis, and cellular degeneration. Incremental demands have prompted the search for newer and alternative resources of natural bioactive compounds with antioxidant properties. The marine environment encompasses almost three-quarters of our planet and is home to many eukaryotic and prokaryotic microorganisms. Because of extreme physical and chemical conditions, the marine environment is a rich source of chemical and biological diversity, and marine microorganisms have high potential as a source of commercially interesting compounds with various pharmaceutical, nutraceutical, and cosmeceutical applications. Bacteria and microalgae are the most important producers of valuable molecules including antioxidant enzymes (such as superoxide dismutase and catalase) and antioxidant substances (such as carotenoids, exopolysaccharides, and bioactive peptides) with various valuable biological properties and applications. Here, we review the current knowledge of these bioactive compounds while highlighting their antioxidant properties, production yield, health-related benefits, and potential applications in various biological and industrial fields.Entities:
Keywords: antioxidant; bacteria; carotenoids; exopolysaccharides; microalgae
Mesh:
Substances:
Year: 2019 PMID: 31905716 PMCID: PMC7024282 DOI: 10.3390/md18010028
Source DB: PubMed Journal: Mar Drugs ISSN: 1660-3397 Impact factor: 5.118
Several carotenoids and their applications in different fields.
| Carotenoids | Examples of Biological Properties, Functions, and Benefits to Human Health | Other Applications | Reference |
|---|---|---|---|
| Astaxanthin |
Antioxidant properties Anti-cancer Anti-male infertility Anti-hepatotoxicity effects Anti-inflammatory effects Anti-diabetic nephropathy Anti-cardiovascular diseases Anti-neurodegenerative diseases |
As a food coloring agent As feed additives | [ |
| Lutein |
Antioxidant properties Anti-cancer Stroke prevention Ocular protective effects Retinitis prevention Anti-diabetic retinopathy Anti-cardiovascular diseases Cataract and age-related macular degeneration prevention |
As a food coloring agent Used in poultry feeding | [ |
| β-carotene |
Antioxidant properties Liver fibrosis prevention Provitamin A functionality Night blindness prevention Anti-neurodegenerative diseases Skin photoprotection against UV light Acute and chronic coronary syndromes prevention |
As a food coloring agent As food supplements | [ |
| Lycopene |
Antioxidant properties Anti-cancer Gene regulation activity Antiulcer activity Immune modulation Radiation protection |
As a food coloring agent | [ |
| Canthaxanthin |
Antioxidant properties Anti-cardiovascular diseases Tan color creation Antitumoral activity Provitamin a functionality Immune system stimulation |
As a food coloring agent As an additive for the feed of dogs, cats, ornamental fish, birds, and other pets | [ |
| Fucoxanthin |
Antioxidant properties Anti-obesity Anti-cancer Anti-malarial effects Bone-protective effects Anti-inflammatory effects Anti-hepatotoxicity effects |
N.A.* | [ |
| Zeaxanthin |
Antioxidant properties Anti-diabetic retinopathy Acute and chronic coronary syndromes prevention Cataract and age-related macular degeneration prevention Visual function maintenance Anti-cardiovascular diseases |
As a food coloring agent Used in poultry feeding | [ |
| β-Cryptoxanthin |
Antioxidant properties Anti-cancer Osteoporosis prevention Bone formation stimulation and protective effects |
N.A.* | [ |
| Bacterioruberin |
Antioxidant properties Anti-cancer |
N.A.* | [ |
| Sioxanthin |
Antioxidant properties |
N.A.* | [ |
| Salinixanthin |
Antioxidant properties Anti-cancer |
N.A.* | [ |
| Saproxanthin |
Antioxidant properties Apoptosis-inducing effects |
N.A.* | [ |
| Violaxanthin |
Antioxidant properties Anti-inflammatory effects in macrophages |
As a food coloring agent | [ |
| Myxol |
Antioxidant property Anti-cancer |
N.A.* | [ |
| Echinenone |
Antioxidant properties |
N.A.* | [ |
| Phytoene |
Antioxidant properties Antitumoral activity |
N.A.* | [ |
| Siphonaxanthin |
Antiproliferative activity |
N.A.* | [ |
N.A.*: not available.
Figure 1Several famous microalgae and the carotenoids produced by them. Only carotenoids produced at a high amount are mentioned in the diagram.
Figure 2Various carotenoid-producing marine bacteria and their natural growth condition. Only a few well-known marine bacteria and the carotenoids they produce at a high rate are featured in the diagram.
Some carotenoid-producing microalgae.
| Name | Carotenoid(s) | Molecular Formula | Production Yield | Source | Reference |
|---|---|---|---|---|---|
| β-carotene | C40H56 | 100 mg/L |
| [ | |
| Astaxanthin | C40H52O4 | 40–45 mg/g |
| [ | |
| α-carotene | C40H56 | 2.7 ± 0.5 mg/g |
| [ | |
| Zeaxanthin | C40H56O2 | 11.3 ± 1.6 mg/g |
| [ | |
| Lutein | C40H56O2 | 6.6 ± 0.9 mg/g |
| [ | |
| Astaxanthin | C40H52O4 | 357 mg/L |
| [ | |
| Astaxanthin | C40H52O4 | 10.3 mg/L |
| [ | |
| Lutein | C40H56O2 | 153,009.7 μg/g |
| [ | |
| β-cryptoxantin | C40H56O | 334.9 μg/g |
| [ | |
| Canthaxanthin | C40H52O2 | 8.5 mg/g |
| [ | |
| Auroxanthin | C40H56O4 | 38.5 μg/g |
| [ | |
| Violaxanthin | C40H56O4 | 38.1 μg/g |
| [ | |
| Neochrome | C40H56O4 | 65.2 μg/g |
| [ | |
| Neoxanthin | C40H56O4 | 199.7 μg/g |
| [ | |
| Zeaxanthin | C40H56O2 | 2170.3 μg/g |
| [ | |
| β-carotene | C40H56 | 4314.3 μg/g |
| [ | |
| α-carotene | C40H56 | 4232.5 μg/g |
| [ | |
| Lutein | C40H56O2 | 3.8 mg/L. day |
| [ | |
| β-carotene | C40H56 | 296 mg/kg |
| [ | |
| Lutein | C40H56O2 | 1.05 mg/L. h |
| [ | |
| Astaxanthin | C40H52O4 | 2.3 mg/g |
| [ | |
| Lutein | C40H56O2 | 35 mg/L | Not mentioned | [ | |
| Fucoxanthin | C42H58O6 | 15.7 mg/g |
| [ | |
| Lutein | C40H56O2 | 0.6 ± 0.1 mg/g |
| [ | |
| Lutein | C40H56O2 | 5–6 g/L |
| [ | |
| Fucoxanthin | C42H58O6 | 80 mg/L |
| [ | |
| Fucoxanthin | C42H58O6 | 18.23 ± 0.54 mg/g |
| [ | |
| Fucoxanthin | C42H58O6 | 2.24 ± 0.01 mg/g |
| [ | |
| Fucoxanthin | C42H58O6 | 4.92 ± 0.11 mg/g |
| [ |
Some carotenoid-producing marine bacteria.
| Name | Carotenoid(s) | Molecular Formula | Production Yield | Source | Reference |
|---|---|---|---|---|---|
| Canthaxanthin | C40H52O2 | 0.73 mg/L |
| [ | |
| Canthaxanthin | C40H52O2 | 1.70 mg/L |
| [ | |
| Canthaxanthin | C40H52O2 | 5.31 mg/L | [ | ||
| Canthaxanthin | C40H52O2 | 9.3 mg/L | [ | ||
| Canthaxanthin | C40H52O2 | 2,194.09 ± 0.3 μg/L |
| [ | |
| β-carotene | C40H56 | 189.91 ± 0.5 μg/L |
| [ | |
| Bacterioruberin | C50H76O4 | 3,818.45 ± 0.01 μg/L |
| [ | |
| 3-Hydroxyechinenone | C40H54O2 | 250.95 ± 0.9 μg/L |
| [ | |
| Astaxanthin | C40H52O4 | 89.7 μg/L |
| [ | |
| Adonixanthin | C40H54O3 | 323.38 μg/L |
| [ | |
| Bacterioruberin | C50H76O4 | 11.47 mg/L | [ | ||
| Lycopene | C40H56 | 0.104 mg/L | [ | ||
| β-carotene | C40H56 | 0.128 mg/L | [ | ||
| Zeaxanthin | C40H56O2 | N.D.* |
| [ | |
|
| [ | ||||
| Zeaxanthin | C40H56O2 | N.D.* |
| [ | |
| Zeaxanthin | C40H56O2 | N.D.* |
| [ | |
| 3 | C40H56O2 | N.D.* |
| [ | |
| 3 | C40H56O3 | N.D.* | [ | ||
| 3R,2′S-myxol | C40H56O3 | N.D.* |
| [ | |
| α-bacterioruberin | C50H76O4 | N.D.* | [ | ||
|
| |||||
| α-bacterioruberin | C50H76O4 | N.D.* |
| [ | |
| Salinixanthin | C61H92O9 | N.D.* |
| [ | |
| Zeaxanthin | C40H56O2 | N.D.* |
| [ | |
| Zeaxanthin | C40H56O2 | N.D.* |
| [ | |
| Zeaxanthin | C40H56O2 | N.D.* |
| [ | |
| Zeaxanthin | C40H56O2 | N.D.* |
| [ |
N.D.*: not determined.
Non-exhaustive recent examples of antioxidant exopolysaccharide (EPS)-producing marine bacteria.
| Marine Bacteria | EPS Concentration | DPPH• Scavenging | O2−• Scavenging | Free Radical Scavenging | Nitric Oxide RadicalScavenging | Ferrous Ions Chelation Capacity | Reduction of Ferric Ions Power (1) | Lipid Peroxidation | •OH Scavenging | Reference |
|---|---|---|---|---|---|---|---|---|---|---|
|
| 20–100 µg/mL (O2−•)50–250 µg/mL (•OH) | - | 12–85% | - | - | - | - | - | 20–55% | [ |
| 0.25–1.0 mg/mL | IC50 = 0.61 mg/mL | IC50 = 0.33 mg/mL | - | - | - | 7.5–20 µg eq. ascorbic acid | - | - | [ | |
| 100 µg/mL | 86% | 61% | 38% | 64% | 64% | 0.003 | 60% | 62% | [ | |
| 250 µg/mL | 98% | 72% | 43% | 76% | 70% | 0.005 | 69% | 74% | ||
| 500 µg/mL | 99% | 83% | 47% | 85% | 70% | 0.005 | 75% | 85% | ||
|
| 20–100 mg/mL | 96% | - | - | - | - | - | - | - | [ |
|
| 20–100 mg/mL | 82% | - | - | - | - | - | - | - | |
|
| 20–100 mg/mL | 77% | - | - | - | - | - | - | - | |
|
| 20–100 mg/mL | 98% | - | - | - | - | - | - | - | |
|
| 20–100 mg/mL | 85% | - | - | - | - | - | - | - | |
|
| 20–100 mg/mL | 97% | - | - | - | - | - | - | - | |
| 5–250 mg/L | - | 43% | - | - | - | 0.35 | - | 51% | [ | |
|
| 20–100 mg/mL | 83% | - | - | - | - | - | - | - | [ |
|
| 20–100 mg/mL | 84% | - | - | - | - | - | - | - | |
| 30–200 μg/mL | EC50 = 77 μg/mL | - | - | - | - | - | - | - | [ | |
| (0.1)–10.0 mg/mL | 55% | 28% | - | - | - | - | - | 52% | [ | |
|
| ETW1: 8 mg/mL | 88% | - | - | - | - | - | 79% | 89% | [ |
| ETW2: 8 mg/mL | 77% | - | - | - | - | - | 71% | 77% | ||
| 0.25–1.0 mg/mL | IC50 = 0.44 mg/mL | IC50 = 0.65 mg/mL | - | - | - | 5–12.5 µg eq. ascorbic acid | - | - | [ | |
| <50 µg/mL | 69% | - | - | - | - | - | - | - | [ | |
| 0.1–3.5 mg/mL | 20–80% | 23–90% | - | - | - | 0.9–1.7 | - | 25–90% | [ | |
| 0.25–1.0 mg/mL | IC50 = 0.49 mg/mL | none | - | - | - | 10–24 µg eq. ascorbic acid | - | - | [ | |
| 0–3 mg/mL | IC50 = 180 µg/mL | IC50 = 149 µg/mL | - | - | - | 0.2–0.8 | - | IC50 = 340 µg/mL | [ | |
| <50 µg/mL | 63% | - | - | - | - | - | - | - | [ | |
| 5–20 µg/mL | - | IC50 = 20 μg/mL | - | - | - | - | - | IC50 = 60 μg/mL | [ | |
| 20–100 mg/mL | 80% | - | - | - | - | - | - | - | [ | |
| (0.1)–10 mg/mL | 49% | 27% | - | - | - | - | - | 59% | [ |
DPPH•: 1,1diphenyl-2-picryl-hydrazyl free radical; %: corresponds to inhibition %; (1) In absorbance (A700); ETW1 and ETW2: Two water-soluble extracellular polysaccharides derived from Edwardsiella tarda.
Antioxidant assays performed on EPS from microalgae.
| Microalgae | EPS Composition | Antioxidant and Scavenging Activity Determination Assays | Reference |
|---|---|---|---|
| Glc, Rha, Gal, Man, Xyl, protein, sulfate | DPPH, ABTS radical scavenging assays | [ | |
|
| N.D.* | DPPH, LPO, hydroxyl and superoxide anion radical scavenging assays, mouse red blood cell hemolysis assay | [ |
| Xyl, Glc, Gal, Ara, Rha, Man, GlcA, sulfates | TBA, FOX, and DCFH assays | [ | |
|
| Xyl, Glc, Gal, GlcA, sulfates | LPO assay in mouse liver homogenates, hydroxyl and superoxide anion radical scavenging assays | [ |
|
| Xyl, Glc, Gal, Rha, GlcA, sulfates | FOX and TAOC assays, hydroxyl and superoxide anion radicals scavenging assays | [ |
|
| N.D.* | DPPH, LPO, hydroxyl and superoxide anion radicals scavenging assays, mouse red blood cell hemolysis assay | [ |
N.D.*: Not determined, TBA: thiobarbituric acid, FOX: ferrous oxidation-xylenol orange, DCFH: dichlorofluorescein, TAOC: total antioxidant capacity, LPO: lipid peroxidation, DPPH: 1,1-diphenyl-2-picrylhydrazyl radical, Glc: glucose, Rha: rhamnose, Gal: galactose, Man: mannan, Xyl: xylose, Ara: arabinose, GlcA: glucoronic acid.